GelSana attended Diabetic Foot Conference (DF Con) in sunny Los Angeles in September 2022. So many great talks and new connections made. It was incredibly energizing to be among so many people working towards solving the diabetic foot ulcer problem!
GelSana was thrilled to be selected as one of the presenting companies at Colorado BioScience Association’s Investor and Partnering Conference in Vail, CO, in September 2022! :li:activity:6975900338176294912/
GelSana Therapeutics was selected to participate in the TechConnect World Innovation Conference 2022 Medical Innovation Challenge. This conference took place in Baltimore, MD, and was GelSana’s first time presenting on an international stage. Melissa Krebs presented a pitch about GelSana…
The University of Northern Colorado’s Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge. After competing in the semifinals, five Open Division participants and five Collegiate Division participants presented their pitches in the finals event on March 9.…
The Advanced Industries Accelerator (AIA) Program announced that 22 Colorado companies and five researchers were approved to receive Proof of Concept and Early Stage Capital and Retention grants for a total of $6,350,918 million in funding. GelSana Therapeutics, Inc. is one of the 22 companies…
LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored as Rising Star of the Year Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the Innovation Forward: Forum + Awards Celebration, held on October 12 at the Hyatt Regency. The…
GelSana receives seed round investment to advance novel wound healing solutions Golden, CO and Fort Collins, CO – Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana). GelSana will use…
DENVER — Yesterday, the Colorado Small Business Development Center (SBDC) Network’s statewide TechSource program completed its first-ever virtual Tech Venture Accelerator for Women (TVX-W). Ten female-owned, Colorado-based technology businesses were chosen for the program based on their proposals for Small Business Innovation Research (SBIR) or…
In this “Funded in Colorado” episode, Innosphere’s CEO Mike Freeman sits down with Melissa Krebs, PhD, founder and CEO of GelSana Therapeutics, a Colorado-based MedTech company that is developing novel hydrogels that heal wounds faster and with less inflammation, to talk about…
Melissa Krebs will use the funding from Innosphere Ventures to accelerate GelSana Therapeutics’ product development plan A biotech startup company founded by a Mines professor has received pre-seed funding to help commercialize hydrogel bandages capable of slowly releasing medication. GelSana…
